NFKB1 and atrial fibrillation: Statins have an established anti-inflammatory effect by inhibiting IL-6, tumor necrosis factor α (TNF-α) production, and nuclear factor kappa B (NF-κB) activation, and suppressing initiation and progression of AF [38].